First trimester combined screening for Trisomy 21 in Hong Kong: outcome of the first 10,000 cases

References

• Gilbert R E, Augood C, Gupta R, Ades A E, Logan S, Sculpher M, van Der Meulen J H. Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies. BMJ 2001; 323: 423–425
   PubMed Web of Science ®Google Scholar
• Nicolaides K H. First-trimester screening for chromosomal abnormalities. Semin Perinatol 2005; 29: 190–194
   PubMed Web of Science ®Google Scholar
• von Kaisenberg C S, Gasiorek-Wiens A, Bielicki M, Bahlmann F, Meyberg H, Kossakiewicz A, Pruggmayer M, Kamin G, Fritzer E, Harris C, et al. Screening for trisomy 21 by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11–14 weeks: a German multicenter study. J Matern Fetal Neonatal Med 2002; 12: 89–94
   PubMedGoogle Scholar
• Stenhouse E J, Crossley J A, Aitken D A, Brogan K, Cameron A D, Connor J M. First-trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practice. Prenat Diagn 2004; 24: 774–780
   PubMed Web of Science ®Google Scholar
• Wøjdemann K R, Shalmi A C, Christiansen M, Larsen S O, Sundberg K, Brocks V, Bang J, Nørgaard-Pedersen B, Tabor A. Improved first-trimester Down syndrome screening performance by lowering the false-positive rate: a prospective study of 9941 low-risk women. Ultrasound Obstet Gynecol 2005; 25: 227–233
   PubMed Web of Science ®Google Scholar
• Malone F D, Canick J A, Ball R H, Nyberg D A, Comstock C H, Bukowski R, Berkowitz R L, Gross S J, Dugoff L, Craigo S D, et al. First-trimester or second trimester screening, or both, for Down's syndrome. N Engl J Med 2005; 353: 2001–2011
   PubMed Web of Science ®Google Scholar
• Hadlow N C, Hewitt B G, Dickinson J E, Jacoby P, Bower C. Community-based screening for Down's Syndrome in the first trimester using ultrasound and maternal serum biochemistry. BJOG 2005; 112: 1561–1564
   PubMed Web of Science ®Google Scholar
• Leung T Y, Chan L W, Leung T N, Fung T Y, Sahota D S, Spencer K, Lau T K. First-trimester combined screening for trisomy 21 in a predominantly Chinese population. Ultrasound Obstet Gynecol 2007; 29: 14–17
   PubMed Web of Science ®Google Scholar
• Leung T Y, Spencer K, Leung T N, Fung T Y, Lau T K. Higher median levels of free β-hCG and PAPP-A in the first trimester of pregnancy in a Chinese ethnic group. Implication for first trimester combined screening for Down's syndrome in the Chinese population. Fetal Diagn Ther 2006; 21: 140–143
   Google Scholar
• Spencer K. Screening for trisomy 21 in twin pregnancies in the first trimester: does chorionicity impact on maternal serum free β-hCG or PAPP-A levels. Prenat Diagn 2001; 21: 715–717
   PubMed Web of Science ®Google Scholar
• Avgidou K, Papageorghiou A, Bindra R, Spencer K, Nicolaides K H. Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies. Am J Obstet Gynecol 2005; 192: 1761–1767
   PubMed Web of Science ®Google Scholar
• FMF Regulations for Certification in the 11–13 + 6 weeks scan. http://www.fetalmedicine.com/f-downs.htm.
   Google Scholar
• Caughey A B, Kuppermann M, Norton M E, Washington A E. Nuchal translucency and first trimester biochemical markers for down syndrome screening: a cost-effectiveness analysis. Am J Obstet Gynecol 2002; 187: 1239–1245
   PubMed Web of Science ®Google Scholar
• Chan Y M, Leung T N, Leung T Y, Fung T Y, Chan L W, Lau T K. The utility assessment of Chinese pregnant women towards the birth of a baby with Down syndrome compared to a procedure-related miscarriage. Prenat Diagn 2006; 26: 819–824
   PubMed Web of Science ®Google Scholar
• Kuppermann M, Nease R F, Learman L A, Gates E, Blumberg B, Washington A E. Procedure-related miscarriages and Down syndrome-affected births: implications for prenatal testing based on women's preferences. Obstet Gynecol 2000; 96: 511–516
   PubMed Web of Science ®Google Scholar
• Grobman W A, Dooley S L, Welshman E E, Pergament E, Calhoun E A. Preference assessment of prenatal diagnosis for Down syndrome: is 35 years a rational cutoff. Prenat Diagn 2002; 22: 1195–1200
   PubMed Web of Science ®Google Scholar
• Leung T N, Chau M CM, Chang J J, Leung T Y, Fung T Y, Lau T K. Attitudes towards termination of pregnancy among Hong Kong Chinese women attending prenatal diagnosis counseling clinic. Prenat Diagn 2004; 24: 546–551
   PubMed Web of Science ®Google Scholar
• Drake H, Reid M, Marteau T. Attitudes towards termination for fetal abnormality: comparisons in three European countries. Clin Genet 1996; 49: 134–140
   PubMed Web of Science ®Google Scholar
• de Graaf I M, Tijmstra T, Bleker O P, van Lith J M. Womens' preference in Down syndrome screening. Prenat Diagn 2002; 22: 624–629
   PubMed Web of Science ®Google Scholar
• Spencer K, Aitken D. Factors affecting women's preference for type of prenatal screening test for chromosomal anomalies. Ultrasound Obstet Gynecol 2004; 24: 735–739
   PubMed Web of Science ®Google Scholar
• Leung T Y. First trimester combined screening for Down syndrome: experience from Hong Kong. The 20th Asian and Oceanic Congress of Obstetrics and Gynaecology; 2007 September 21–25; Tokyo, Abstract book; 122p
   Google Scholar
• Chan L W, Chau M C, Leung T Y, Fung T Y, Leung T N, Lau T K. Expectation and knowledge of women undergoing first-trimester combined screening for Down syndrome in a Chinese population. Prenat Diagn 2005; 25: 1248–1252
   PubMed Web of Science ®Google Scholar
• Lau T K, Leung T Y, Fung T Y, Chan L W, Sahota D S, Leung T N. Outcome of 1355 consecutive transabdominal chorionic villus samplings in 1351 patients. CMJ 2005; 20: 1675–1681
   Google Scholar
• Snijders R J, Sebire N J, Nicolaides K H. Maternal age and gestational age-specific risk for chromosomal defects. Fetal Diagn Ther 1995; 10: 356–367
   PubMed Web of Science ®Google Scholar
• Dugoff L, Hobbins J C, Malone F D, Porter T F, Luthy D, Comstock C H, Hankins G, Berkowitz R L, Merkatz I, Craigo S D, et al. First-trimester maternal serum PAPP-A and free-β subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol 2004; 191: 1446–1451
   PubMed Web of Science ®Google Scholar